FDA approves gene therapy to treat adults with Metastatic Synovial Sarcoma
Among the 44 patients in the trial who received Tecelra, the overall response rate was 43.2 per cent and the median duration of…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.